|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Nov 2018
|
|
Related companies:
Giant Med-Pharma Services, Inc. |
I-MED Pharma Inc. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Nov 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Nov 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Nov 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 30 Oct 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
SUZHOU, China, Oct. 29, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced the initiation in China of a Phase I clinical trial for CS3006, a small-molecule MEK1/2 inhibitor. A first patient has been successfully enrolled and dosed at the 307th Hospital of the Chinese People's... Read more ›› |
|
By: PR Newswire Association LLC. - 30 Oct 2018
|
|
Related companies:
CStone Pharmaceuticals |
|
|
Most Powerful Sequencer to Date Read more ›› |
|
By: PR Newswire Association LLC. - 28 Oct 2018
|
|
Related companies:
Beijing BGI-GBI Biotech Co., Ltd. |
Beijing Genomics Institute (BGI) |
|
|
Most Powerful Sequencer to Date Read more ›› |
|
By: PR Newswire Association LLC. - 27 Oct 2018
|
|
Related companies:
Beijing BGI-GBI Biotech Co., Ltd. |
Beijing Genomics Institute (BGI) |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 26 Oct 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 25 Oct 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 25 Oct 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 25 Oct 2018
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 25 Oct 2018
|
|
Related companies:
111, Inc. (formerly Gangling Group) |
|
|
Green Valley Pharmaceutical Company has submitted New Drug Applications and Market Authorization to China Food and Drug Administration (CFDA) for Sodium Oligomannurarate (GV-971) Read more ›› |
|
By: PR Newswire Association LLC. - 25 Oct 2018
|
|
Related companies:
Shanghai Green Valley Pharmaceutical Co., Ltd. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 24 Oct 2018
|
|
Related companies:
BeiGene, Ltd. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 24 Oct 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
SUZHOU, China, Oct. 23, 2018 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced that the United States Food and Drug Administration (FDA) has recently granted approval to the company's Investigational New Drug (IND) application for the independently developed recombinant humanized... Read more ›› |
|
By: PR Newswire Association LLC. - 24 Oct 2018
|
|
Related companies:
CStone Pharmaceuticals |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Oct 2018
|
|
|
SYDNEY, Oct. 23, 2018 /PRNewswire/ -- NeuClone Ltd, a biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it has commenced first-in-human dosing of its Herceptin(®) (trastuzumab) biosimilar candidate, in a Phase I clinical trial. Read more ›› |
|
By: PR Newswire Association LLC. - 23 Oct 2018
|
|
Related companies:
SERUM INSTITUTE OF INDIA LTD |
National Vaccine & Serum Institute Co., Ltd. |
NeuClone Pty. Limited |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Oct 2018
|
|
Related companies:
ShangPharma Corp. (SHP) |
Shire plc |
|
|
|
|
|
Biotechgate Global Database ›
